Page last updated: 2024-12-10
raphanusamic acid
Description
raphanusamic acid: RN given for (R)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
raphanusamic acid : A thiazolidinemonocarboxylic acid that is 2-thioxo-1,3-thiazolidine with the carboxy group located at position 4 (the R-enantiomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 3035791 |
CHEBI ID | 136957 |
SCHEMBL ID | 1149837 |
MeSH ID | M0300868 |
Synonyms (21)
Synonym |
(4r)-(-)-2-thioxo-4-thiazolidinecarboxylic acid, 99% |
raphanusamic acid |
(r)-(-)-2-thioxo-4-thiazolidinecarboxylic acid |
(4r)-2-thioxo-4-thiazolidinecarboxylic acid |
CHEBI:136957 |
(4r)-2-sulfanylidene-1,3-thiazolidine-4-carboxylic acid |
98169-56-3 |
(4r)-5-carboxythiazolidine-2-thione |
(4r)-2-thioxo-1,3-thiazolidine-4-carboxylic acid |
AKOS015893999 |
(4r)-(-)-2-thioxo-4-thiazolidinecarboxylic acid |
SCHEMBL1149837 |
(r)thiazolidine-2-thione-4-carboxylic acid |
TS-00120 |
(4r)-2-sulfanyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid |
DTXSID00243495 |
(r)-2-thioxothiazolidine-4-carboxylic acid |
(4r)-()-2-thioxo-4-thiazolidinecarboxylic acid |
(4r)-(-)-2-thioxothiazolidine-4-carboxylic acid |
A916396 |
(r)-2-thioxothiazolidine-4-carboxylicacid |
Roles (3)
Role | Description |
Arabidopsis thaliana metabolite | Any plant metabolite that is produced by Arabidopsis thaliana. |
mouse metabolite | Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). |
xenobiotic metabolite | Any metabolite produced by metabolism of a xenobiotic compound. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
Class | Description |
thiazolidinemonocarboxylic acid | A thiazolidine or thiazolidine derivative carrying a single carboxy substituent. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 20.21
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 20.21 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.37 (4.65) | Search Engine Demand Index | 15.26 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |